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When a Cypr~d~na luciferin analog {the title compound) was added to a macrophage suspension in Hank’s 
balanced salt solution (control), the system emitted a weak, but detectable light, which was not altered in 
the presence of superoxide dismutase. The same system, however, emitted a much stronger Iight, just after 
the addition of a trigger, opsonized zymosan. The luminescence was suppressed to the control level in the 
presence of superoxide dismutase, while it was only slightly influenced, if at all, by NaN,, a scavenger of 
singlet oxygen and an inhibitor of myeloperoxidase. Some other results obtained also indicate the participa- 
tion of0; in the luciferin analog-de~ndent Iuminescence in macrophages during phagocytosis. 
~ac~o~hage Superoxide anion (Cypridina) Luciferin analog Chem~~u~inesce~c~ 
1.. INTRODUCTION 
During the process of phagocytosis or chemical 
activation, macrophages (MCP), as well as poly- 
morphonuclear leukocytes, undergo remarkable al- 
terations in oxidative metabolism. One such change 
is the generation of 02 11-31, which can be moni- 
tored by one-electron reduction of ferricytochrome 
c added to the system. The method of assay, how- 
ever, requires a relatively large number of cells. 
Allen and Roose [4] first described the luminol-de- 
pendent luminescence in activated alveolar or peri- 
tonea MCP, which could be involved in the oxida- 
tion of luminol to excited aminophthalate ion by 
0:. This chemiluminescent probe is highly sensi- 
tive for the detection of 02, but not specific for 
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02. This report describes that a chemiluminescent 
probe with a Cypridina luciferin analog, 2-methyl- 
6-phenyI-3,~-dihydroimid~o[l,2-aJpyrazin-3-one 
(CLA), is very useful for investigating the ability 
of 02 generation by MCP during phag~~osis. 
2, MATERIALS AND METHODS 
2.1. Mucrophuges 
Mouse peritoneal or human peripheral blood 
MCP were prepared according to Kumagai et al.’ 
[SJ and resuspended in Hank’s balanced saIt so& 
tion (HBSS). 
2.2. &ZZJJ~~ and special reagents 
Mifk xanthine oxidase (X0) and bovine erythro- 
cyte superoxide dismutase (SUD) were purchased 
from Boehringer Mannheim and Sigma, respec- 
tively. The former was dialysed overnight against 
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0.01 M phosphate buffer (pH 7.4) at 4°C. Opso- 
nized zymosan (OZ) was prepared by the method 
of Johnston et al. [6] and its amount expressed as 
dry weight of zymosan used. CLA was synthesized 
according to [7]. 6 mg CLA was dissolved in 100 ml 
distilled water and stored at -20%‘. The molar ex- 
tinction coefficient of CLA in water was 8900 at 
410nm. Luminol from Aldrich (18,26mg) was 
dissolved in a slightly alkaline solution which was 
then brought to pH 7.4 with HCl, the volume ad- 
justed to 1OOml with water and stored at -20°C. 
2.3. Assays 
X0 activity was determined as described by 
Roussos [8]. 02 production was monitored by the 
reaction of ferricytochrome c according to [9]. 
2.4. Incubation 
The incubation mixture contained MCP-OZ or 
hypoxanthine-X0, CLA or luminol, and HBSS 
(1.8-1.9 ml} in a total volume of 2ml. In some 
cases, 5 x IO-’ M SOD or 5 x low4 M NaN3 was 
added to and one and two components excluded 
from the mixture. All components, except for OZ 
and CLA or X0 and CLA, were preincubated for 
3 min and the reaction initiated by the simultaneous 
addition of the other two components. CLA- or 
luminol-dependent luminescence was monitored 
with a luminescence reader (Aloka, BLD-101) as in 
[lo]. During luminescence measurement, he incu- 
bation mixture was rotatively agitated at 37°C in 
the luminescence reader. Light yield (integrated 
light intensity) was determined as in [9-II]. 
3. RESULTS 
No detectable emission was obtained in HBSS 
containing MCP or both 02 and MCP. When 
CLA in water was added to an MCP suspension 
(or none) in HBSS a detectable light was emitted 
which did not increase with time and was not 
altered in the presence of SOD (fig.1 and inset, 
CONT). On the other hand, the same system con- 
taining CLA and MCP in HBSS emitted a strong 
light, just after the addition of the trigger, OZ. 
Light intensity (counts/min) as a function of time 
increased, reached its m~imum and decreased 
(fig.1 and inset, CLA). The CLA-dependent lumi- 
nescence induced by phagocytosis (CLA minus 
CONT) was completely abolished by SOD (fig.1 
28 
and inset, CLA + SOD), while it was only slightly 
influenced, if at all, by NaN3 (fig.1, CLA + AZ). 
The system containing luminol at the same concen- 
tration as that of CLA did not emit enough light 
during phagocytosis (fig.1 and inset, L). With a 
fixed CLA concentration, increasing the number 
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Fig. 1. CLA-dependent luminescence during phagocyto- 
sis. The incubation mixture contained 1 FM CLA (CLA) 
or I,uM luminol (L), 1 x lo6 MCP (human peripheral 
blood), 2 mg OZ, 5 x lo-’ M SOD (CLA + SOD) or 
none and HBSS. NaN3 (CLA + AZ) at 5 x 10m4 M was 
added to the incubation mixture instead of SOD. For 
control (CONT), both MCP and OZ or only 02 was 
omitted from the above system. Inset: incubation mix- 
ture and conditions essentiahy the same as above, save 
that 4 x 10’ MCP (mouse peritoneal exudate) was added 
instead of human MCP. 
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Fig.2 Effect of the number of cells on CLA-dependent 
luminescence (A,B). The incubation mixture contained 
~,GM CLA (0) or 1pM luminol (of, 2 mg OZ, MCP 
(human peripheral blood) and HBSS. Maximal light 
intensity (max. counts/min) was corrected for control 
excluding OZ. 
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of MCP resulted in a linear increase in the maxi- 
mal light intensity (corrected for control) up to 
1 x lo6 cells/2ml (fig.2A). With the data in 
fig.2A, the plot l/max. counts vs l/number of 
MCP yielded a straight line (fig.2B). To prove the 
participation of 02 in luminescence of CLA, CLA 
was exposed to a hypoxanthine-X0 system, in 
which the number of enzyme units was varied and 
the luminescence detected. As shown in fig.3, 
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Fig.3. Luminescence of CLA in a hypoxanthine-X0 
system. The incubation mixture contained I,uM CLA, 
43pM hypoxanthine, X0, and HBSS. Maximal light 
intensity was corrected for control excluding X0. 
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Fig.4. Comparison of light yield with 02 production 
during phagocytosis. The incubation mixture for the 
luminescent probe contained 15pM CLA, 1.25 x lo6 
MCP (human peripheral blood) per ml, 1 mg OUml and 
HBSS in a total volume of 2ml. The same system, but 
excluding CLA and containing 0.1 mM ferricytochrome 
c in a total volume of 20 ml, was used for the measure- 
ment of 0; production. The values were corrected for 
controls excluding OZ. 
maximal light intensity (corrected for control ex- 
cluding X0) increased linearly with increasing 
number of X0 units. Thus, one can derive the fol- 
lowing experimental expression (eqn 1) 
max. counts/min = 294 x X0 unit (1) 
In all cases, SOD completely abolished the en- 
zyme-induced luminescence (not shown). Correla- 
tion of light yield with 02 production during 
phagocytosis is shown in fig.4. This clearly indi- 
cates that 0; production is parallel to CLA-depen- 
dent light yield. Thus the rate of 02 generation 
should be proportional to CLA-dependent light 
intensity during phagocytosis. 
4. DISCUSSION 
The luminescent probe with CLA was first ap- 
plied to the quantitative determination of xanthine 
and X0 activity [ 121. CLA, however, becomes 
luminescent if the reaction mixture contains some 
oxidants such as Hz02 and a catalytic amount of 
Fe3+ [12]. A non-specific luminescence also ap- 
peared when CLA in water was mixed with HBSS. 
However, luminescence of this type is strikingly 
different from CLA-dependent luminescence in 
phagocytizing MCP, with respect to the intensity 
at, time course of and SOD effect on the lumines- 
cence. The results obtained with a well-known 
OS-generating system and the comparison of light 
yield with 02 production durng phagocytosis 
clearly indicate the participation of 02 in CLA- 
dependent luminescence. Singlet oxygen, 02 (‘Ag 
type), may also participate in the luminescence of 
CLA. Cadenas et al. [13] have reported the pos- 
sible formation of ‘02 in Con A-activated MCP. 
Furthermore, CLA also becomes luminescent when 
added to myeloperoxidase Hz02 in HBSS [ 141. 
Even though myeloperoxidase activity in MCP is 
zero or much lower than that in polymorpho- 
nuclear leukocytes [15], the activity in MCP could 
be detected by a very sensitive method [16]. How- 
ever, the involvement of IO2 or a myeloperoxi- 
dase-H202-Cl system in CLA-dependent lumines- 
cence during phagocytosis would be neglected, be- 
cause of the slight effect, if any, of azide, an in- 
hibitor of myeloperoxidase [17] and a scavenger of 
‘02 [18], on the luminescence response. Thus, the 
ability of Or production by MCP during 
29 
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phagocytosis can be simply expressed as X0 units, 
by ~~~~~~t~~~~g the maximal light i~te~~~~~ 
measured in a phagocytizing system (corrected for 
central) into eqn I. 
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